MA25352A1 - Nouvelle methode de traitement - Google Patents

Nouvelle methode de traitement

Info

Publication number
MA25352A1
MA25352A1 MA26356A MA26356A MA25352A1 MA 25352 A1 MA25352 A1 MA 25352A1 MA 26356 A MA26356 A MA 26356A MA 26356 A MA26356 A MA 26356A MA 25352 A1 MA25352 A1 MA 25352A1
Authority
MA
Morocco
Prior art keywords
processing method
new processing
new
processing
Prior art date
Application number
MA26356A
Other languages
English (en)
Inventor
Creighton P Conley
John A Roush
Kevin H Storm
Original Assignee
Beecham Pharm Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27383840&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA25352(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Pharm Pte Ltd filed Critical Beecham Pharm Pte Ltd
Publication of MA25352A1 publication Critical patent/MA25352A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Peptides Or Proteins (AREA)
MA26356A 1999-04-13 2001-10-12 Nouvelle methode de traitement MA25352A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12907499P 1999-04-13 1999-04-13
US15072799P 1999-08-25 1999-08-25
US15981399P 1999-10-15 1999-10-15

Publications (1)

Publication Number Publication Date
MA25352A1 true MA25352A1 (fr) 2001-12-31

Family

ID=27383840

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26356A MA25352A1 (fr) 1999-04-13 2001-10-12 Nouvelle methode de traitement

Country Status (44)

Country Link
EP (4) EP1269996A1 (fr)
JP (2) JP4880125B2 (fr)
KR (1) KR100634937B1 (fr)
CN (1) CN100382782C (fr)
AP (1) AP1806A (fr)
AR (1) AR031068A1 (fr)
AT (2) ATE242629T1 (fr)
AU (1) AU767177B2 (fr)
BE (2) BE1013309A5 (fr)
BG (1) BG65006B1 (fr)
BR (1) BRPI0009719B8 (fr)
CA (1) CA2366304C (fr)
CO (1) CO5170471A1 (fr)
CZ (1) CZ298801B6 (fr)
DE (3) DE10017883A1 (fr)
DK (3) DK200000133U3 (fr)
DZ (1) DZ3150A1 (fr)
EA (1) EA004310B1 (fr)
ES (2) ES2202004T3 (fr)
FI (2) FI20000863A7 (fr)
FR (1) FR2792198A1 (fr)
GB (1) GB2351661B (fr)
GR (1) GR1003560B (fr)
HU (1) HU229097B1 (fr)
IE (1) IE20000271A1 (fr)
IL (2) IL145580A0 (fr)
IT (1) ITMI20000788A1 (fr)
MA (1) MA25352A1 (fr)
MX (1) MXPA01010377A (fr)
MY (1) MY119953A (fr)
NL (2) NL1014914C1 (fr)
NO (1) NO329694B1 (fr)
NZ (1) NZ514575A (fr)
OA (1) OA11926A (fr)
PE (1) PE20010053A1 (fr)
PL (1) PL197448B1 (fr)
PT (2) PT1044680E (fr)
RO (1) RO120817B1 (fr)
SE (1) SE0001330L (fr)
SI (2) SI1044680T1 (fr)
SK (1) SK285140B6 (fr)
TR (1) TR200102963T2 (fr)
TW (1) TWI235067B (fr)
WO (1) WO2000061116A2 (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9407386D0 (en) 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
AR004510A1 (es) * 1995-09-07 1998-12-16 Smithkline Beecham Plc Composiciones que comprenden amoxicilina y clavulanato, procedimientos para su preparacion y el uso de las composiciones para la fabricacion de unmedicamento
SE9802973D0 (sv) 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
WO2002030392A2 (fr) * 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Nouvelle formulation
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
JP2005515966A (ja) 2001-07-06 2005-06-02 エンドー ファーマシューティカルズ， インコーポレイティド 鎮痛薬としての使用のための６−ヒドロキシ−オキシモルホンの経口投与
GB0117618D0 (en) * 2001-07-19 2001-09-12 Phoqus Ltd Pharmaceutical dosage form
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
EP1492511B3 (fr) 2002-04-09 2012-05-02 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
JP2005528383A (ja) * 2002-04-10 2005-09-22 ミラー，フレッド，エイチ． 多重相・複数コンパートメントカプセルシステム
US20050042289A1 (en) * 2003-04-29 2005-02-24 Yamanouchi Pharma Technologies, Inc. Tablets and methods for modified release of hydrophylic and other active agents
US8062672B2 (en) 2003-08-12 2011-11-22 Shionogi Inc. Antibiotic product, use and formulation thereof
EP1541129A1 (fr) * 2003-12-12 2005-06-15 Cimex AG Composition effervescente pharmaceutique contenant de l'amoxicilline et du clavulanate
WO2005079752A2 (fr) * 2004-02-11 2005-09-01 Rubicon Research Private Limited Compositions pharmaceutiques a liberation controlee presentant une meilleure biodisponibilite
WO2005099672A1 (fr) * 2004-04-13 2005-10-27 Ranbaxy Laboratories Limited Formulation pharmaceutique a liberation modifiee contenant de l'amoxicilline et du clavulanate
EP1880716A1 (fr) * 2006-07-19 2008-01-23 Sandoz AG Kit comprenant un produit actif métastable à l'acide et un produit actif stable à l'acide
CN101578096A (zh) * 2006-10-10 2009-11-11 潘威斯脱药物公司 稳健的缓释制剂
TR200909787A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
TR201000686A1 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
TR201000687A1 (tr) 2010-01-29 2011-08-22 Bi̇lgi̇ç Mahmut Aktif madde olarak sefiksim ve klavulanik asit içeren efervesan formülasyonlar
TR201000688A2 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
US11154495B2 (en) * 2015-04-07 2021-10-26 Church & Dwight Co., Inc. Multicomponent gummy compositions with soft core
CN109394718B (zh) * 2018-11-15 2021-04-27 石药集团中诺药业（石家庄）有限公司 一种阿莫西林分散片及其制备方法
CN110051637A (zh) * 2019-05-21 2019-07-26 葵花药业集团北京药物研究院有限公司 阿莫西林克拉维酸钾制剂及其制备方法
US20250312324A1 (en) * 2022-04-29 2025-10-09 Overseas Pharmaceuticals, Ltd. Prolonged-release oral solid formulation of pirfenidone

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2964817D1 (en) * 1978-09-06 1983-03-24 Beecham Group Plc Pharmaceutical compositions containing two beta-lactam derivatives
IL58461A0 (en) * 1978-10-27 1980-01-31 Beecham Group Ltd Intramammary compositions comprising a clavulanic acid salt
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
GB9007945D0 (en) * 1990-04-07 1990-06-06 Beecham Group Plc Pharmaceutical formulation
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
AU5863894A (en) * 1993-01-22 1994-08-15 Smithkline Beecham Plc Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
GB9311030D0 (en) * 1993-05-28 1993-07-14 Smithkline Beecham Corp Pharmaceutical formulations
IL109770A0 (en) * 1993-05-29 1994-11-28 Smithkline Beecham Corp Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
GB9407386D0 (en) * 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
ITMI941169A1 (it) * 1994-06-06 1995-12-06 Smithkline Beecham Farma Formulazioni farmaceutiche
GB9416599D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
GB9416600D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
AR004510A1 (es) * 1995-09-07 1998-12-16 Smithkline Beecham Plc Composiciones que comprenden amoxicilina y clavulanato, procedimientos para su preparacion y el uso de las composiciones para la fabricacion de unmedicamento
GB9616536D0 (en) * 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
CA2280857A1 (fr) * 1997-02-14 1998-08-20 Smithkline Beecham Laboratoires Pharmaceutiques Formulations pharmaceutiques comprenant de l'amoxycilline et du clavulanate
SK121099A3 (en) * 1997-03-11 2000-06-12 Almag Al Process and apparatus for coating metals
SE9700885D0 (sv) * 1997-03-12 1997-03-12 Astra Ab New pharmaceutical formulation
WO1998042311A1 (fr) * 1997-03-25 1998-10-01 Takeda Chemical Industries, Ltd. Composition pharmaceutique adherant a la muqueuse gastro-intestinale
JP3746901B2 (ja) * 1997-10-15 2006-02-22 ユニ・チャーム株式会社 開閉自在容器
GB9815532D0 (en) * 1998-07-17 1998-09-16 Lek Pharmaceutical & Cvhemical Pharmaceutical suspension formulation
GB9818927D0 (en) * 1998-08-28 1998-10-21 Smithkline Beecham Plc Pharmaceutical formulation
US6225304B1 (en) * 1999-02-17 2001-05-01 Pharmaceutical Solutions, Inc. Soluble forms of amoxicillin and treatment of animals

Also Published As

Publication number Publication date
AU767177B2 (en) 2003-11-06
CO5170471A1 (es) 2002-06-27
PL339591A1 (en) 2000-10-23
WO2000061116A3 (fr) 2001-02-01
GB2351661A (en) 2001-01-10
PT1044680E (pt) 2003-10-31
CN1382040A (zh) 2002-11-27
SI1044680T1 (en) 2003-12-31
BRPI0009719B8 (pt) 2021-05-25
NL1014915C2 (nl) 2001-02-12
BR0009719B1 (pt) 2014-09-30
EP1270005A3 (fr) 2006-05-17
ITMI20000788A1 (it) 2001-10-11
HUP0001471A2 (en) 2001-03-28
IL145580A0 (en) 2002-11-10
FI20000863L (fi) 2000-10-13
SK5342000A3 (en) 2000-11-07
ES2202004T3 (es) 2004-04-01
HU0001471D0 (en) 2000-06-28
EA200101075A1 (ru) 2002-04-25
KR20020015312A (ko) 2002-02-27
EP1044680B1 (fr) 2003-06-11
DE20006626U1 (de) 2000-10-19
AR031068A1 (es) 2003-09-10
ITMI20000788A0 (it) 2000-04-11
FI20000863A7 (fi) 2000-10-13
CZ298801B6 (cs) 2008-02-06
FI4823U1 (fi) 2001-02-16
DE10017883A1 (de) 2000-10-26
EP1044680A1 (fr) 2000-10-18
EP1269997A1 (fr) 2003-01-02
BG65006B1 (bg) 2006-12-29
NZ514575A (en) 2004-05-28
TWI235067B (en) 2005-07-01
PT102450A (pt) 2001-02-01
FI20000863A0 (fi) 2000-04-11
NO329694B1 (no) 2010-12-06
FR2792198A1 (fr) 2000-10-20
SE0001330L (sv) 2000-10-14
MY119953A (en) 2005-08-30
HUP0001471A3 (en) 2001-10-29
AP2001002284A0 (en) 2001-12-31
AP1806A (en) 2007-12-14
RO120817B1 (ro) 2006-08-30
PE20010053A1 (es) 2001-03-10
JP2011256180A (ja) 2011-12-22
PL197448B1 (pl) 2008-03-31
SK285140B6 (sk) 2006-07-07
AU5702000A (en) 2000-11-14
ES2190692A1 (es) 2003-08-01
IE20000271A1 (en) 2001-04-04
DZ3150A1 (fr) 2000-10-19
NL1014915A1 (nl) 2000-10-16
DK1044680T3 (da) 2003-09-29
KR100634937B1 (ko) 2006-10-17
DK200000133U3 (da) 2000-07-28
AT4327U1 (de) 2001-06-25
ES2190692B1 (es) 2004-11-16
WO2000061116A2 (fr) 2000-10-19
MXPA01010377A (es) 2002-10-23
HK1032741A1 (en) 2001-08-03
OA11926A (en) 2006-04-12
SE0001330D0 (sv) 2000-04-11
EP1269996A1 (fr) 2003-01-02
HU229097B1 (en) 2013-07-29
NO20001870L (no) 2000-10-16
BE1013309A5 (fr) 2001-11-06
CN100382782C (zh) 2008-04-23
GR1003560B (el) 2001-03-16
FIU20000164U0 (fi) 2000-04-11
SI20304A (sl) 2001-02-28
BR0009719A (pt) 2002-01-08
NO20001870D0 (no) 2000-04-11
PT102450B (pt) 2003-09-30
DE60003255D1 (de) 2003-07-17
DE60003255T2 (de) 2004-05-06
GB2351661B (en) 2001-10-10
ATE242629T1 (de) 2003-06-15
DK200000602A (da) 2000-10-14
CA2366304A1 (fr) 2000-10-19
NL1014914C1 (nl) 2000-10-16
JP4880125B2 (ja) 2012-02-22
EP1270005A2 (fr) 2003-01-02
CZ20001311A3 (cs) 2000-11-15
BE1012733A6 (fr) 2001-02-06
BG104329A (en) 2001-11-30
CA2366304C (fr) 2004-06-29
GB0008923D0 (en) 2000-05-31
IL145580A (en) 2007-05-15
EA004310B1 (ru) 2004-02-26
JP2002541187A (ja) 2002-12-03
TR200102963T2 (tr) 2002-02-21

Similar Documents

Publication Publication Date Title
MA25352A1 (fr) Nouvelle methode de traitement
MA25351A1 (fr) Nouvelle methode de traitement
EP1358650A4 (fr) Procede de traitement multimodal
EP1393708A4 (fr) Procede de traitement des cheveux
EP1423811A4 (fr) Traitement de transaction
FR2814945B1 (fr) Procede de traitement de la canitie
EP1100119A4 (fr) Procede de traitement au plasma
DE10084419T1 (de) Automatisierte Prozesslinien
EP1332349A4 (fr) Systeme de traitement automatise
DE60138995D1 (de) Betrugssicheres Verarbeitungsverfahren
FI991186L (fi) Menetelmä ternimaidon käsittelemiseksi
DE60215096D1 (de) Optisches Verarbeitungssystem
FI991220L (fi) Menetelmä massan käsittelemiseksi
EP1366858A4 (fr) Polisseuse et procede de polissage
FR2788234B1 (fr) Procede de chanfreinage
PT1278816E (pt) Metodo para processar azeitonas
DE60033589D1 (de) Bildverarbeitung
DE60213924D1 (de) Bildverarbeitungsverfahren
EP1389105A4 (fr) Methode de traitement
DE69905294D1 (de) Bildverarbeitung
MA25522A1 (fr) Procede de traitement de copd
FI20021342L (fi) Kuvankäsittelymenetelmä
EP1282411A4 (fr) Methode de traitement anticancereux
EP0997450A4 (fr) PROCEDE DE REDUCTION DE NO x
DE60005700D1 (de) Fadenverarbeitungssystem